2025 Immunization Independent Pharmacies 
Drug Topics
AUGUST 10, 2025
Kimberly Jones, RPh, is the pharmacy manager of Austin Pharmacy & Medical Supplies, located in Cockeysville, Maryland, about 25 minutes north of Baltimore. During pharmacy school, my internship was at an independent pharmacy in my hometown, and I realized I preferred that atmosphere,” Jones said. “I
Drug Topics
JULY 7, 2025
McKesson ideaShare 2025 will take place this week in Nashville, Tennessee, and will include educational sessions, keynote sessions, networking events, and hands-on activities. This year’s conference is taking place from July 10 to 13 in Nashville, Tennessee. There is a total of 11 continuing education credits for the 3-day conference.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 4, 2025
Pharmacy closures have become commonplace within the industry as of late, with thousands of shutdowns since 2010 and a trend that’s showing significantly more pharmacy closures than openings. They're providing clinical advice, testing, immunizations, and many other necessary services to maintain good health. References 1.
Drug Topics
AUGUST 6, 2025
August 6, 2025 By Brian Nowosielski Ginny Langbehn Commentary Video Sponsored Content From Scripts to Screens: AAP’s Ginny Langbehn Shares Winning Digital Strategies for Independent Pharmacies In today’s digital-first world, being visible online is no longer optional for independent pharmacies—it’s essential.
Drug Topics
JULY 18, 2025
Published online June 29, 2025:100006. Accessed July 18, 2025. A collaborative and patient-centered approach is crucial in improving polypharmacy outcomes, according to a study published in Intelligent Hospital. Optimizing patient care: an inclusive review of polypharmacy and the vital role of pharmacists in mitigation.
Drug Topics
JULY 2, 2025
She highlighted the challenges of maintaining accurate, transparent vaccine guidance, focusing on the importance of trusted health care providers helping patients understand immunization strategies. This schedule also helped dictate insurance coverage of those recommended vaccines.
Drug Topics
JULY 2, 2025
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were safe and effective as adjunctive therapies for patients with type 1 diabetes (T1D) and overweight or obesity, according to an abstract presented at the American Diabetes Association 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025.
Expert insights. Personalized for you.
Let's personalize your content